{"page_content": "13\nAPELLIS SUSTAINABILITY REPORT 2021\nTraining and Development\nAt Apellis, we are committed to ensuring our people have the \nknowledge and skills to succeed and develop transformative \nmedicines for patients. We created our first Leadership \nDevelopment Program in 2021, and plan to launch our \nMatrix Leadership Development training program in 2022 for \nindividuals working on our program teams. In 2022, we will \nlaunch broad-based training for all employees. We are proud \nto support advanced education and certifications for all full-\ntime and part-time employees depending on their role. We \nalso have formalized training programs for managerial, \nleadership, and patient- and customer-facing employees. \nWe actively monitor training hours completed by our \nworkforce on the topics of our Code, unconscious bias, \nand DEI. All our employees are eligible for quarterly \nDevelopment Conversations, which focus on \nimproving their current role performance and career \nplanning for the future. \nAPELLIS LEADERSHIP DEVELOPMENT TOPICS\nLeadership styles\nProviding \ndirection\nCoaching and \nfeedback\nDevelopment and \nfeedback\nEffective decision \nmakingInfluence \nmanagement \nChange  \nmanagement \nEffective \ninterviewing skills\nBehavioral \ninterview\n13", "metadata": {"source": "NASDAQ_APLS_2021.pdf", "page": 14, "parser": "pypdf", "split_method": "page", "run_time": "2024-05-29 08:35:04"}, "type": "Document"}